These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 34629076)
21. Validation of Knock-Out Caco-2 TC7 Cells as Models of Enterocytes of Patients with Familial Genetic Hypobetalipoproteinemias. Bordat C; Vairo D; Cuerq C; Halimi C; Peiretti F; Penhoat A; Vieille-Marchiset A; Gonzalez T; Michalski MC; Nowicki M; Peretti N; Reboul E Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771214 [TBL] [Abstract][Full Text] [Related]
22. Chylomicron retention disease: a long term study of two cohorts. Peretti N; Roy CC; Sassolas A; Deslandres C; Drouin E; Rasquin A; Seidman E; Brochu P; Vohl MC; Labarge S; Bouvier R; Samson-Bouma ME; Charcosset M; Lachaux A; Levy E Mol Genet Metab; 2009 Jun; 97(2):136-42. PubMed ID: 19285442 [TBL] [Abstract][Full Text] [Related]
23. Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein. Charcosset M; Sassolas A; Peretti N; Roy CC; Deslandres C; Sinnett D; Levy E; Lachaux A Mol Genet Metab; 2008 Jan; 93(1):74-84. PubMed ID: 17945526 [TBL] [Abstract][Full Text] [Related]
24. Chylomicron retention disease: a rare aetiology of failure to thrive. Sunkoj Y; Yu Z; Altaf A; Talathi S BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38749523 [TBL] [Abstract][Full Text] [Related]
25. Chylomicron Retention Disease: Failure to Thrive and Abdominal Distention in an Infant. Nayak K; Fuentebella J JPGN Rep; 2022 Feb; 3(1):e145. PubMed ID: 37168760 [TBL] [Abstract][Full Text] [Related]
27. Establishment of reference values of α-tocopherol in plasma, red blood cells and adipose tissue in healthy children to improve the management of chylomicron retention disease, a rare genetic hypocholesterolemia. Cuerq C; Restier L; Drai J; Blond E; Roux A; Charriere S; Michalski MC; Di Filippo M; Levy E; Lachaux A; Peretti N Orphanet J Rare Dis; 2016 Aug; 11(1):114. PubMed ID: 27520363 [TBL] [Abstract][Full Text] [Related]
28. Studying lipoprotein trafficking in zebrafish, the case of chylomicron retention disease. Schlegel A J Mol Med (Berl); 2015 Feb; 93(2):115-8. PubMed ID: 25572701 [No Abstract] [Full Text] [Related]
29. Carotenoids in familial hypobetalipoproteinemia disorders: Malabsorption in Caco2 cell models and severe deficiency in patients. Bordat C; Cuerq C; Halimi C; Vairo D; Blond E; Restier L; Poinsot P; Duclaux-Loras R; Peretti N; Reboul E J Clin Lipidol; 2024; 18(1):e105-e115. PubMed ID: 37989694 [TBL] [Abstract][Full Text] [Related]
30. Sar1b transgenic male mice are more susceptible to high-fat diet-induced obesity, insulin insensitivity and intestinal chylomicron overproduction. Levy E; Spahis S; Garofalo C; Marcil V; Montoudis A; Sinnet D; Sanchez R; Peretti N; Beaulieu JF; Sane A J Nutr Biochem; 2014 May; 25(5):540-8. PubMed ID: 24657056 [TBL] [Abstract][Full Text] [Related]
31. Anderson's disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities. Silvain M; Bligny D; Aparicio T; Laforêt P; Grodet A; Peretti N; Ménard D; Djouadi F; Jardel C; Bégué JM; Walker F; Schmitz J; Lachaux A; Aggerbeck LP; Samson-Bouma ME Clin Genet; 2008 Dec; 74(6):546-52. PubMed ID: 18786134 [TBL] [Abstract][Full Text] [Related]
32. Low rate of production of apolipoproteins B100 and AI in 2 patients with Anderson disease (chylomicron retention disease). Ouguerram K; Zaïr Y; Kasbi-Chadli F; Nazih H; Bligny D; Schmitz J; Aparicio T; Chétiveaux M; Magot T; Aggerbeck LP; Samson-Bouma ME; Krempf M Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1520-5. PubMed ID: 22441101 [TBL] [Abstract][Full Text] [Related]
33. Novel missense mutations of SAR1B gene in an infant with chylomicron retention disease. Treepongkaruna S; Chongviriyaphan N; Suthutvoravut U; Charoenpipop D; Choubtum L; Wattanasirichaigoon D J Pediatr Gastroenterol Nutr; 2009 Mar; 48(3):370-3. PubMed ID: 19274794 [No Abstract] [Full Text] [Related]
34. Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease. Cuerq C; Henin E; Restier L; Blond E; Drai J; Marçais C; Di Filippo M; Laveille C; Michalski MC; Poinsot P; Caussy C; Sassolas A; Moulin P; Reboul E; Charriere S; Levy E; Lachaux A; Peretti N J Lipid Res; 2018 Sep; 59(9):1640-1648. PubMed ID: 30021760 [TBL] [Abstract][Full Text] [Related]
35. The intracellular transport of chylomicrons requires the small GTPase, Sar1b. Shoulders CC; Stephens DJ; Jones B Curr Opin Lipidol; 2004 Apr; 15(2):191-7. PubMed ID: 15017362 [TBL] [Abstract][Full Text] [Related]
36. Chylomicron retention disease--the role of ultrastructural examination in differential diagnosis. Boldrini R; Biselli R; Bosman C Pathol Res Pract; 2001; 197(11):753-7. PubMed ID: 11770019 [TBL] [Abstract][Full Text] [Related]
37. SAR1B GTPase is necessary to protect intestinal cells from disorders of lipid homeostasis, oxidative stress, and inflammation. Sané A; Ahmarani L; Delvin E; Auclair N; Spahis S; Levy E J Lipid Res; 2019 Oct; 60(10):1755-1764. PubMed ID: 31409740 [TBL] [Abstract][Full Text] [Related]
38. Complex genetic architecture in severe hypobetalipoproteinemia. Wang LR; McIntyre AD; Hegele RA Lipids Health Dis; 2018 Mar; 17(1):48. PubMed ID: 29540175 [TBL] [Abstract][Full Text] [Related]
39. Lipids Responsible for Intestinal or Hepatic Disorder: When to Suspect a Familial Intestinal Hypocholesterolemia? Sissaoui S; Cochet M; Poinsot P; Bordat C; Collardeau-Frachon S; Lachaux A; Lacaille F; Peretti N J Pediatr Gastroenterol Nutr; 2021 Jul; 73(1):4-8. PubMed ID: 33853111 [TBL] [Abstract][Full Text] [Related]